Table 5.
Factors associated with awareness of COVID-19
| Awareness | AOR1 | 95% CI1 | p-value | ||
|---|---|---|---|---|---|
| Characteristic | Poor | Good | |||
| Age, median (IQR) | 34 (29, 41) | 34 (29, 41) | 1.03 | 0.97, 1.09 | 0.302 |
| Sex | |||||
| Female | 75 (35%) | 21 (37%) | Reference | Reference | |
| Male | 140 (65%) | 36 (63%) | 1.03 | 0.52, 2.07 | 0.932 |
| Hospital level | |||||
| Primary hospital | 94 (44%) | 11 (19%) | Reference | Reference | |
| Secondary hospital | 26 (12%) | 12 (21%) | 4.59 | 1.69, 12.8 | 0.003 |
| Tertiary hospital | 95 (44%) | 34 (60%) | 2.93 | 1.35, 6.72 | 0.008 |
| Educational level | |||||
| BPharm | 119 (55%) | 25 (44%) | Reference | Reference | |
| Masters | 36 (17%) | 13 (23%) | 1.33 | 0.56, 3.12 | 0.513 |
| PharmD | 48 (22%) | 16 (28%) | 1.42 | 0.61, 3.27 | 0.409 |
| PhD | 4 (1.9%) | 1 (1.8%) | 0.65 | 0.03, 6.30 | 0.744 |
| Other | 8 (3.7%) | 2 (3.5%) | 1.45 | 0.20, 6.95 | 0.671 |
| Work experience | |||||
| < 5 years | 58 (27%) | 17 (30%) | Reference | Reference | |
| 5 to 9 years | 63 (29%) | 13 (23%) | 0.60 | 0.18, 2.01 | 0.409 |
| 10 years and above | 94 (44%) | 27 (47%) | 0.57 | 0.22, 1.49 | 0.253 |
| Attendance in workshops | |||||
| No workshop attendance | 31 (14%) | 9 (16%) | Reference | Reference | |
| Only one attendance | 27 (13%) | 9 (16%) | 0.95 | 0.28, 3.18 | 0.940 |
| Two or more attendance | 157 (73%) | 39 (68%) | 0.49 | 0.20, 1.28 | 0.131 |
| Receiving enough education previously about epidemics/pandemics | |||||
| No | Reference | Reference | |||
| Yes | 107 (50%) | 40 (70%) | 2.15 | 1.09, 4.35 | 0.030 |
| Following the latest coronavirus updates on treatment | |||||
| No | Reference | Reference | |||
| Yes | 175 (81%) | 53 (93%) | 3.58 | 1.13, 16.1 | 0.053 |